References
James V.H.T., Reed M.J. Steroid hormones and human cancer. In: Iacobelli S., King R.J.B., Lindner H.R., Lippman M.E. (Eds.), Hormones and cancer. Raven Press, New York, 1980, p. 471.
Tseng L., Gurpide E. Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97: 825, 1975.
Anderson D.C. Sex hormone binding globulin. Clin. Endocrinol. (Oxf.) 3: 69, 1974.
Longcope C. The significance of steroid production by peripheral tissue. In: Scholler R. (Ed.), Endocrinology of the ovary. Editions Sepe, Paris, 1978, p. 23.
James V.H.T., Reed M.J., Folkerd E.J. Studies of oestrogen metabolism in postmenopausal women with cancer. J. Steroid Biochem. 15: 235, 1981.
Kirschner M.A., Cohen F.B., Ryan C. Androgen-oestrogen production rates in postmenopausal women with breast cancer. Cancer Res. 38: 4029, 1978.
Vermeulen A., Verdonk L., van der Straeten M., Orie M. Capacity of the testosterone binding globulin in human plasma and the influence of specific binding of testosterone on its metabolic clearance rate. J. Clin. Endocrinol. Metab. 29: 1470, 1969.
Siiteri, P.K._Hammond G.L., Nisker J.A. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike M.C., Siiteri P.K., Welsch C.W. (Eds.), Banbury Report No. 8. Hormones and Cancer, Cold Spring Harbour Laboratory, 1981, p 87.
Siiteri P.K., MacDonald P.C. Role of extraglandular estrogen in human endocrinology. In: Greep R.O., Astwood E.B. (Eds.), Handbook of physiology. American Physiological Society, Washington D.C, 1973, Vol. 2, p. 615.
MacDonald P.C., Edman C.D., Hemsell D.L., Porter J.C., Siiteri P.K. Effect of obesity on conversion of plasma androstenedione to estrone in women with and without endometrial cancer. Am. J. Obstet. Gynecol. 130: 448, 1978.
Reed M.J., Hutton J.D., Baxendale P.M., James V.H.T., Jacobs H.S., Fisher R.P. The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer. J. Steroid Biochem. 11: 905, 1979.
Thijssen J.H.H., Wiegerink M.A.H.M., Poortman J. Estrone at the cellular level in target tissues in vivo in postmenopausal women. J. Steroid Biochem. 9: 893, 1979.
Judd H.L., Davidson B.J., Frumar A.M., Shamonki I.M., Lagasse L.D., Ballon S.C. Serum androgens and oestrogens in postmenopausal women with and without endometrial cancer. Am. J. Obstet. Gynecol. 136: 859, 1980.
McFayden I.J., Prescott R.J., Groom G.V., Forrest A.P.M., Golder M.P., Fahmy D.R., Griffiths K. Circulating hormone concentrations in women with breast cancer. Lancet 2: 1100, 1976.
Drafta D., Schindler A.E., Milcu St. M., Keller E., Stroe E., Horodniceanu E., Balanescu I. Plasma hormones in pre-and postmenopausal breast cancer. J. Steroid Biochem. 13: 793, 1980.
Benjamin F., Deutsch S. Plasma levels of fractionated oestrogens and pituitary hormones in endometrial carcinoma. Am. J. Obstet. Gynecol. 126: 638, 1976.
Moore J.W., Clark G.M.G., Bulbrook R.D., Hayward J.L., Murai J.T., Hammond G.L., Siiteri P.K. Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int. J. Cancer 29: 17, 1982.
Pardridge W.M., Mietus L.J., Frumar A.M., Davidson B.J., Judd H.L. Effects of human serum on transport of testosterone and oestradiol into rat brain. Am. J. Physiol. 239: 103, 1980.
Siiteri P.K. Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer. J. Endocrinol. 89: 119 P, 1981.
Wyndner E.L. Dietary factors related to breast cancer. Cancer 46: 899, 1980.
Nimrod A., Ryan K.J. Aromatization of androgens by human abdominal and breast fat tissue. J. Clin. Endocrinol. Metab. 40: 367, 1975.
Smuk M., Schwers J. Aromatization of androstenedione by human adult liver in vitro. J. Clin. Endocrinol. Metab. 45: 1009, 1977.
Schindler A.E. Steroid metabolism of foetal tissues II Conversion of androstenedione to estrone. Am. J. Obstet. Gynecol. 123: 265, 1975.
Schweikert H.U., Milewich L., Wilson J.D. Aromatization of androstenedione by cultured human fibroblasts. J. Clin. Endocrinol. Metab. 43: 785, 1976.
Longcope C., Pratt J.H., Schneider S.H., Fineberg S.E. Aromatization of androgens by muscle and adipose tissue in vivo J. Clin. Endocrinol. Metab. 46: 146, 1978.
Naftolin F., Ryan K.J., Petro Z. Aromatization of androstenedione by the diencephalon. J. Clin. Endocrinol. Metab. 33: 368, 1971.
Hemsell D.L., Grodin J.M., Brenner P.F., Siiteri P.K., McDonald P.C. Plasma precursors of estrogen. II Correlation of the extent of conversion of plasma androstenedione to oestrone with age. J. Clin. Endocrinol. Metab. 38: 476, 1974.
Schindler A.E., Ebert A., Friedrich E. Conversion of androstenedione to oestrone by human fat tissue. J. Clin. Endocrinol. Metab. 35: 627, 1972.
Forney P.J., Milewich L., Chen G.T., Garlock J.L., Schwarz B.E., Edman C.D., MacDonald P.C. Aromatization of androstenedione to oestrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age and endometrial neoplasia. J. Clin. Endocrinol. Metab. 53: 192, 1981.
Rizkallah T.H., Tovell H.M.M., Kelly W.G. Production of oestrone and fractional conversion of circulating androstenedione to oestrone in women with endometrial carcinoma. J. Clin. Endocrinol. Metab. 40: 1045, 1975.
Folkerd E.J., James V.H.T. Studies on the activity of 17 β-hydroxysteroid dehydrogenase in human adipose tissue. J. Steroid Biochem. 16: 539, 1982.
Folkerd E.J., Reed M.J., James V.H.T. Oestrogen production in adipose tissue from normal women and women with endometrial cancer in vitro. J. Steroid Biochem. 16: 297, 1982.
Erickson G.F., Hsueh A.J.W., Quigley H.E., Rebar R.W., Yen S.S.C. Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J. Clin. Endocrinol. Metab. 49: 514, 1979.
Moon Y.S., Tsang B.K., Simpson C., Armstrong D.T. 17 β oestradiol biosynthesis in cultured granulosa and thechal cells of human ovarian follicles: stimulation by follicle stimulating hormone. J. Clin. Endocrinol. Metab. 47: 263, 1978.
Folkerd E.J., Jacobs H.S._van der Spuy Z., James V.H.T. Failure of FSH to influence aromatization in human adipose tissue. Clin. Endocrinol. (Oxf.) 16: 621, 1982.
Simpson E.R., Ackerman G.E., Smith M.E., Mendelson C.R. Estrogen formation in stromal cells of adipose tissue of women: Induction by glucocorticoids. Proc. Natl. Acad. Sci. US-Biol Sci. 78: 5690, 1981.
Bulbrook R.D., Hayward J.L., Thomas B.S. The relation between the urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids and the fate of patients after mastectomy. Lancet 1: 9, 1964.
Wang D.Y. Plasma androgens in breast cancer. In: Griffiths K., Cameron E.H.D. (Eds.), The human adrenal gland in relation to breast cancer. Alpha Omega Alpha, Caerphilly, 1969, p. 71.
Rose D.P., Stauber P., Thiel A., Crowley J.J., Milbrath J.R. Plasma dehydroepiandrosterone sulphate, androstenedione and Cortisol, and urinary free Cortisol excretion in breast cancer. Eur. J. Cancer 13: 43, 1977.
Zumoff B., Levin J., Rosenfeld R.S., Markam M., Strain G.W., Fukushima D.K. Abnormal 24 hr-mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulphate in women with primary operable breast cancer. Cancer Res. 41: 3360, 1981.
Carlstrom K., Damber M.G., Furuhjelm M., Joelsson I., Lunnell N.O., Schoultz B. Serum levels of total dehydroepiandrosterone and total oestrone in postmenopausal women with special regard to carcinoma of the uterine corpus. Acta Obstet. Gynecol. Scand. 58: 179, 1979.
Feher T., Halmy L. Dehydroepiandrosterone and dehydroepiandrosterone sulphate dynamics in obesity. Can. J. Biochem. 53: 215, 1975.
Shao A., Nowaczynski W., Kuchel O., Genest J. Secretion rate of dehydroepiandrosterone sulphate in benign essential hypertension as compared to normal subjects. Can. J. Biochem. 48: 1308, 1970.
Sekihara H., Ohsawa N., Kosaka K. Serum dehydroepiandrosterone sulphate and dehydroepiandrosterone levels in essential hypertension. J. Clin. Endocrinol. Metab. 40: 156, 1975.
Yen S.C.C., Chaney C., Judd H.L. Functional aberrations of the hypothalamic pituitary system in the polycystic ovary syndrome: a consideration of the pathogenesis. In: James V.H.T., Serio M., Giusti G. (Eds.), The endo crine function of the human ovary. Academic Press, London, 1976, p.
Abraham G.E., Maroulis G.B. Effect of exogenous estrogen on serum pregnenolone, Cortisol and androgens in postmenopausal women. Obstet. Gynecol. 45: 271, 1975.
Saez S. Corticotrophin secretion in relation to breast cancer. In: Stoll B.A. (Ed.), Mammary cancer and neuroendocrine therapy. Butterworth, London, 1979, p. 101.
Sommers C.S., Meissner W.A. Endocrine abnormalities accompanying human endometrial cancer. Cancer 10: 516, 1957.
Mills I.H., Tait A.D., Galley J. Metabolism of dehydroepiandrosterone sulphate in a patient with 17-hydroxylase deficiency. J. Endocrinol. 43: xlix, 1969.
Mancuso S., Mancuso F.P., Tillinger K.G., Diczfalusy E. Lack of aromatization of circulating dehydroepiandrosterone and dehydroepiandrosterone-sulphate in amenorrhoeic women stimulated with human gonadotropins. Acta Endocrinol. 49: 248, 1965.
Drucher W.D., Blumberg J.M., Gandy H.M., David R.R., Verde A.L. Biologic activity of dehydroepiandrosterone sulphate in man. J. Clin. Endocrinol. Metab. 35: 48, 1972.
James V.H.T., Tunbridge R.D.G., Wilson G.A., Hutton J.D., Jacobs H.S., Rippon A.G. Steroid profiling: A technique for exploring adrenocortical physiology. In: James V.H.T., Serio M., Giusti G., Martini L. (Eds.), The endocrine function of the human adrenal cortex. Academic Press, London, 1978, p. 179.
Poortman J., Thijssen J.H.H. The role of androgens in the aetiology of endometrial cancer: a hypothesis. In: Brush M.G., King R.J.B., Taylor R.W. (Eds.), Endometrial cancer. Bailliere Tindall, London, 1978, p. 375.
Adams J.B., Archibald L., Clarke C. Adrenal dehydroepiandrosterone and human mammary cancer. Cancer Res. 38: 4036, 1978.
Pollow K., Boquoi E., Baumann J., Schmidt-Gollwitzer M., Pollow B. Comparison of the in vitro conversion of estradiol-17 β to estrone of normal and neoplastic human breast tissue. Mol. Cell. Endocrinol. 6: 333, 1977.
Geier A., Horn H., Levij I.S., Lichstein E., Finkelstein M. The metabolism of 3H-estradiol-17 β in human breast cancer in organ culture. Eur. J. Cancer 11: 127, 1975.
Reed M.J., Noel C.T., Johns E.A., Jones D.L, James V.H.T. Oestradiol production and factors that influence the interconversion of oestrone and oestradiol in postmeno- pausal women with endometrial hyperplasia, endometrial cancer or cirrhosis. In: Fioretti P., Martini L., Melis G.B., Yen S.S.C. (Eds.), The Menopause: clinical, endocrinological and patho-physiological aspects. Academic Press, London, 1982, p. 326.
Van Doom L.G., Valstar E., Poortman J. Metabolic fate of intraperitoneally administered 5-androstene-3β, 17 β-diol, estradiol-17 β and their combination in the immature female rat. J. Steroid Biochem. 14: 657, 1980.
Longcope C. Metabolic clearance and blood production rates in postmenopausal women. Am. J. Obstet. Gynecol. 111: 778, 1971.
Clerico A., Del Chicca M.G., Zucchelli G.C., Mariani G., Materazzi F. Radioimmunological determination of free (diffusible) Cortisol in an equilibrium dialysis system. J. Nucl. Med. All. Sci. 22: 5, 1978.
Weder H.G., Schildknecht J., Kesselring P. A new equilibrium dialysing system. Am. Lab. 10: 15, 1971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
James, V.H.T., Folkerd, E.J., Bonney, R.C. et al. Factors influencing estrogen production and metabolism in postmenopausal women with endocrine cancer. J Endocrinol Invest 5, 335–345 (1982). https://doi.org/10.1007/BF03350524
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350524